Franklin Resources’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4K | Sell |
14,020
-200,271
| -93% | -$248K | ﹤0.01% | 2952 |
|
|
2025
Q1 | $253K | Buy |
214,291
+197
| +0.1% | +$232 | ﹤0.01% | 2551 |
|
|
2024
Q4 | $392K | Buy |
214,094
+36,158
| +20% | +$66.2K | ﹤0.01% | 2389 |
|
|
2024
Q3 | $365K | Buy |
+177,936
| New | +$365K | ﹤0.01% | 2414 |
|
|
2024
Q2 | – | Sell |
-86,768
| Closed | -$325K | – | 2935 |
|
|
2024
Q1 | $325K | Buy |
86,768
+66,159
| +321% | +$248K | ﹤0.01% | 2427 |
|
|
2023
Q4 | $202K | Buy |
20,609
+507
| +3% | +$4.97K | ﹤0.01% | 2341 |
|
|
2023
Q3 | $168K | Sell |
20,102
-47,818
| -70% | -$399K | ﹤0.01% | 2359 |
|
|
2023
Q2 | $903K | Buy |
+67,920
| New | +$903K | ﹤0.01% | 1672 |
|
|
2022
Q2 | – | Sell |
-13,446
| Closed | -$123K | – | 2431 |
|
|
2022
Q1 | $123K | Sell |
13,446
-9,215
| -41% | -$84.3K | ﹤0.01% | 2256 |
|
|
2021
Q4 | $463K | Sell |
22,661
-17,490
| -44% | -$357K | ﹤0.01% | 1928 |
|
|
2021
Q3 | $1.03M | Buy |
40,151
+27,244
| +211% | +$696K | ﹤0.01% | 1626 |
|
|
2021
Q2 | $452K | Buy |
12,907
+90
| +0.7% | +$3.15K | ﹤0.01% | 1627 |
|
|
2021
Q1 | $427K | Buy |
12,817
+4,311
| +51% | +$144K | ﹤0.01% | 1630 |
|
|
2020
Q4 | $221K | Buy |
+8,506
| New | +$221K | ﹤0.01% | 1704 |
|